Plunkett Research Online: Anixa Biosciences Inc

ANIXA BIOSCIENCES INC (ANIX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Anixa Biosciences, Inc. is a biotechnology company that develops therapies and vaccines focused on critical unmet needs in oncology and infectious disease. The firm’s programs include the development of a chimeric endocrine receptor T-cell technololgy, a novel form of chimeric antigen recepter T-ce.....



Anixa Biosciences Inc
Ticker: ANIX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 408 708-9808
Fax:
Address: 3150 Almaden Expressway
Suite 250
San Jose, CA 95118 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Biiotechnology
Therapeutics Development
Oncology
Infectious Disease
Contacts Description

Amit Kumar CEO/Chairman of the Board/Director/President
Michael Catelani CFO/Chief Accounting Officer/COO
See More
Anixa Biosciences, Inc. is a biotechnology company that develops therapies and vaccines focused on critical unmet needs in oncology and infectious disease. The firm’s programs include the development of a chimeric endocrine receptor T-cell technololgy, a novel form of chimeric antigen recepter T-ce.....See More See More

Auditor: Haskell & White LLP
Legal Advisor: Duane Morris LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Certainty Therapeutics Inc
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: